3,609
Views
32
CrossRef citations to date
0
Altmetric
Internal Medicine

Translation and validation of the English version of the general medication adherence scale (GMAS) in patients with chronic illnesses

ORCID Icon, , , &
Pages 36-42 | Received 26 Sep 2018, Accepted 02 Feb 2019, Published online: 01 Mar 2019

References

  • Osterberg L, Blaschke T. Adherence to medication. N Engl J Med. 2005;353:487–497.
  • United Nations. Prevention and control of non communicable diseases: report of the Secretary-General 2011 [cited 2018 December]. [Internet]; Available from: http://www.un.org/ga/search/view_doc.asp?symbol=A/66/83&Lang=E
  • Tandon S, Chew M, Eklu-Gadegbeku CK. Validation and psychometric properties of the 8-item Morisky Medication Adherence Scale (MMAS-8) in Type 2 diabetes patients in sub-Saharan Africa. Diabetes Res Clin Pract. 2015;110:129–136.
  • Naqvi AA, Naqvi SB, Zehra F, et al. The cost of poliomyelitis: Lack of cost-of-illness studies on poliomyelitis rehabilitation in Pakistan. Arch Pharma Pract. 2016;7:182–184. doi:10.4103/2045-080X.191988
  • Hussain M, Naqvi SBS, Khan MA, et al. Direct cost of treatment of diabetes mellitus type 2 in Pakistan. Int J Pharm Pharm Sci. 2014;6:261–264.
  • Gera N. Pakistan's Healthcare under Structural Adjustment. Lahore J Econ. 2003;8:65–81.
  • Naqvi AA, Naqvi SBS, Zehra F, et al. Estimation of the direct cost of poliomyelitis rehabilitation treatment to Pakistani patients: a 53-Year Retrospective Study. Appl Health Econ Health Policy. 2018;16:871–878. doi:10.1007/s40258-018-0422-6
  • Naqvi AA, Hassali MA, Rizvi R, et al. Development and Validation of a Novel General Medication Adherence Scale (GMAS) for Chronic Illness Patients in Pakistan. Front Pharmacol. 2018;9:1124. doi:10.3389/fphar.2018.01124
  • Naqvi AA, Hassali MA. Limitations in contemporary self-reported medication adherence questionnaires: the concept and design of the General Medication Adherence Scale (GMAS) originating from a developing country. Curr Med Res Opin. 2019;35(1):1–2. doi:10.1080/03007995.2018.1526169
  • De las Cuevas C, Pe˜ Nate W, García de Cecilia JM, et al. Predictive validity of the Sidorkiewicz instrument in Spanish: Assessing individual drug adherence in psychiatric patients. Int J Clin Hlth Psyc. 2018;18:91–188.
  • Sidorkiewicz S, Tran V-T, Cousyn C, et al. Development and validation of an instrument to assess treatment adherence for each individual drug taken by a patient. BMJ Open. 2016;6:e010510.
  • Naqvi AA, Naqvi SBS, Yazdani N, et al. Understanding the dynamics of Poliomyelitis spread in Pakistan. Iran J Public Health. 2017;46(7):997–998.
  • Naqvi AA, Yazdani N, Ahmad R, et al. Epidemiology of primary amoebic meningoencephalitis-related deaths due to Naegleria fowleri infections from freshwater in Pakistan: An analysis of 8-year dataset. Arch Pharma Pract. 2016;7:119–129. doi:10.4103/2045-080X.191924
  • Shakeel S, Naqvi AA, Iffat W. Emergence of the chikungunya virus (CHIKV) in Pakistan: Mapping the 2016 outbreak. Arch Pharma Pract. [Epub ahead of print] [cited 2018; December]. doi:10.4103/app.app_7_17
  • Abbas A, Yazdani N. Polio dilemma: a wake-up call for Pakistan. Med Sci. 2014;13:88–89.
  • Naqvi AA, Naqvi SBS, Shahid S, et al. Barriers to rehabilitation treatment among poliomyelitis infected patients in Karachi, Pakistan: A mix-methods study. Khyber Med Univ J. 2016;8:12–21.
  • World Health Organization - Noncommunicable Diseases (NCD) Country Profiles. 2014 [cited 2018 December]. [Internet]; Available from: http://www.who.int/nmh/countries/pak_en.pdf
  • Saleem F, Hassali MA, Akmal S, et al. Translation and validation study of Morisky Medication Adherence Scale (MMAS): the Urdu version for facilitating person-centered healthcare in Pakist. Int J Person Centered Med. 2012;2:384–390.
  • Dowrick C, Dixon-Woods M, Holman H, et al. What is chronic illness? Chronic Illness. 2005;1:1–6.
  • Osborne JW, Costello AB. Sample size and subject to item ratio in principle component analysis. Pract Assess Res Evaluat. 2004;9:1–9.
  • Beaton DE, Bombardier C, Guillemin F, et al. Guidelines for the process of cross-cultural adaptation of self-report measures. Spine. 2000;25:3186–3191.
  • Wild D, Grove A, Martin M, et al. Principles of good practice for the translation and cultural adaptation process for Patient-Reported Outcomes (PRO) measures: report of the ISPOR Task force for translation and cultural adaptation. Value Health. 2005;8:94–104.
  • Naqvi AA, Hassali MA, Aftab MT, et al. Development of evidence based disease education literature for Pakistani rheumatoid arthritis patients. Diseases. 2017;5:27. doi:10.3390/diseases5040027
  • Williams B, Brown T. Exploratory factor analysis: A five-step guide for novices. Australasian J Paramedicine. 2010;8:1–13.
  • Jöreskog K, Long JS. Introduction. In: Kenneth A. Bollen and J. Scott Long, editors. Testing structural equation models, Newbury Park (CA): Sage; 1993.
  • Pett AM, Lackey NR, Sullivan JJ. Making sense of factor analysis: the use of factor analysis for instrument development in health care research. Thousand Oaks (CA): Sage; 2003.
  • Hair JF, Jr, Black WC, Babin BJ, et al. Multivariate data analysis. 7th ed. New York (NY): Prentice Hall; 2009.
  • Shima R, Farizah H, Majid HA. The 11-item Medication Adherence Reasons Scale: reliability and factorial validity among patients with hypertension in Malaysian primary healthcare settings. Singapore Med J. 2015;56:460–467.
  • Mulaik SA, James LR, Van Alstine J, et al. Evaluation of goodness-of-fit indices for structural equation models. Psychol Bull. 1989;105:430–445.
  • Kline RB. Principles and practice of structural equation modeling. New York, (USA): The Guilford Press; 2008.
  • Bowling A. Research methods in health: Investigating health and health services. 3rd ed. Berkshire (UK): Open University Press; 2009.
  • De Vellis RF. Scale development: Theory and applications. 26th ed. California (USA): Sage; 1991.
  • Cohen JS. Statistical power analysis for the behavioral sciences. 2nd ed. New Jersey (USA): Lawrence Erlbaum Associates Inc; 1988.
  • Streiner DL, Norman GR. Health measurement scales: A practical guide to their development and use. 2nd ed. New York (NY): Oxford University Press Inc; 1995.
  • Sushil S, Verma N. Questionnaire validation made easy. Eur J Sci Res. 2010;46:172–178.
  • Lahey MA, Downey RG, Saal FE. Intraclass correlations: There’s more there than meets the eye. Psychol Bull. 1983;93:586–595.
  • Zwick WR, Velicer WF. Comparison of five rules for determining the number of components to retain. Psychol Bull. 1986;99:432–442.
  • Toll BA, McKee SA, Martin DJ, et al. Factor structure and validity of the Medication Adherence Questionnaire (MAQ) with cigarette smokers trying to quit. Nicotine Tob Res. 2007;9:597–605.
  • O Iuga A, McGuire MJ. Adherence and health care costs. Risk Manag Healthc Policy. 2014;7:35–44.
  • Kurlander JE, Kerr EA, Krein S, et al. Cost-Related Nonadherence to Medications Among Patients with Diabetes and Chronic pain: factors beyond finances. Diabetes Care. 2009;32:2143–2148.
  • Naqvi AA, Hassali MA, Aftab MT, Nadir MN A qualitative study investigating perceived barriers to medication adherence in chronic illness patients of Karachi, Pakistan. J Pak Med Assoc. 2019: 69:216.
  • Perez-Escamilla B, Franco-Trigo L, Moullin JC, et al. Identification of validated questionnaires to measure adherence to pharmacological antihypertensive treatments. Patient Prefer Adher. 2015;9:569–578.
  • Dunbar-Jacob J, Sereika SM, Houze M, et al. Accuracy of measures of medication adherence in a cholesterol-lowering regimen. West J Nurs Res. 2012;34:578–597.
  • Forbes CA, Deshpande S, Sorio-Vilela F, et al. A systematic literature review comparing methods for the measurement of patient persistence and adherence. Curr Med Res Opin. 2018;34:1613–1625.